Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03100448
Other study ID # T-190
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 24, 2017
Est. completion date May 8, 2019

Study information

Verified date October 2019
Source Nobel Biocare
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A 1-year Clinical Investigation on the On1 Concept.


Description:

This open, prospective, multi-center clinical trial evaluates the On1 Concept for the treatment of patients in need for single tooth replacement or 3-unit bridges in the mandible or maxilla.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date May 8, 2019
Est. primary completion date May 8, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The subject is at least 18 years of age (or age of consent) and has passed cessation of growth. - Obtained informed consent from the subject. - The patient is willing and able to comply with all study related procedures (such as exercising oral hygiene and attending all follow-up procedures). - The subject shall be healthy and compliant with good oral hygiene. - Full-mouth bleeding score (FMBS) lower than 25% [10]. - Full-mouth plaque score (FMPI) lower than 20% [11]. - Suitable for implant treatment in the posterior, pre-molar and canine area in the mandible or maxilla. - The subject shall have a favorable and stable occlusal relationship. - In need of one or multiple single tooth replacements or 3-unit bridges. - Healed sites in need for implant placement (i.e. minimum of 6 weeks post extraction). - The implant sites are free from infection and extraction remnants. - The subject is suitable for a 1-stage surgical procedure. - Sufficient amount of buccal and lingual keratinized mucosa. - The subject has a sufficient amount of bone for placing NobelActive implants with a length of at least 8 mm. - Primary implant stability as assessed by manual hand testing. Exclusion Criteria: - The subject is not able to give her/his informed consent of participating. - Health conditions, which do not permit the surgical (including anesthesia) or restorative procedure. - Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or in subject history. - Any disorders in the planned implant area such as previous tumors, chronic bone disease or previous irradiation in the head/neck area. - Infections in the planned implantation site or adjacent tissue. - Acute, untreated periodontitis in the planned implantation site or adjacent tissue. - Any ongoing application of interfering medication (steroid therapy, bisphosphonate, etc.). - Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake or A1c level above 8%. - Alcohol or drug abuse as noted in subject records or in subject history. - Smoking of >10 cigarettes/day. - Fresh extraction sites (up to 6 weeks). - Severe bruxism or other destructive habits. - Pregnant or lactating women at the time of implant insertion. - Previous bone augmentation (lateral and/or vertical). - Soft tissue augmentation less than 2 months before implant placement.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
On1 Concept
NobelActive implant placement with simultaneous On1 Base placement

Locations

Country Name City State
Belgium Service de Médecine dentaire CHU Sart Tilman Liege
Italy Studio Odontoiatrico Specialistico Cattolica
Lithuania Dental Clinic Auksteja Kaunas LT
Lithuania Dental Clinic Auksteja Kaunas
Lithuania Vilnius Implantology Center Vilnius
Netherlands Tandartspraktijk Staas & Bergmans Hertogenbosch

Sponsors (1)

Lead Sponsor Collaborator
Nobel Biocare

Countries where clinical trial is conducted

Belgium,  Italy,  Lithuania,  Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Marginal bone remodeling The change in the marginal bone level around the implants from baseline to 12-months of follow-up is measured on paired radiographs. 12 months
Secondary Soft tissue outcome (soft tissue height) The change in soft tissue height from baseline to 12-months of follow-up. 12 months
Secondary Component Survival Survival rates of implants as well as On1 components and prosthetics. 12 months
Secondary Component Success Success of implants as well as On1 components and prosthetics by clinical evaluation calculated in a cumulative success rate life table. 12 months
Secondary Patient's pain perception (visual analogue score) The patient's pain perception during the post surgery period is evaluated by the use of a visual analogue score. 3 months
Secondary Patient's oral health related quality of life (OHIP-14) The patient's oral health related quality of life is evaluated by the use of the OHIP-14 questionnaire. 12 months
Secondary Patient's satisfaction with function & esthetics (visual analogue score) The patient's satisfaction with function & esthetics is evaluated by the use of a visual analogue score. 12 months
Secondary Ease of use of the On1 Concept (questionnaire) The ease of use of the On1 Concept is evaluated by the use of a surgeon questionnaire. 12 months
See also
  Status Clinical Trial Phase
Completed NCT03784430 - Soft and Hard Tissue Changes After Immediate Single-tooth Replacement N/A
Completed NCT02096978 - Comparing Implant Stability Using Two Accepted Techniques for Implant Sites N/A
Completed NCT04048239 - Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation N/A
Recruiting NCT06150768 - Porcelain-fused-to-metal Versus Zirconia Implant- Supported in Mandibular Kennedy Class II N/A
Completed NCT02175550 - A 5-year Clinical Evaluation Study on NobelReplace Conical Connection Implants N/A
Completed NCT01066780 - ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users N/A
Completed NCT05190614 - Radiographic Evaluation of a Star-shaped Incision Technique
Completed NCT04706078 - Clinical and Radiographic Evaluation of a Cross-shaped Incision Technique
Recruiting NCT04935944 - Effect of FOV and mA on Metal Artifacts on CBCT
Not yet recruiting NCT05387421 - Evaluating the PrimeTaper EV Implant for 5 Years N/A
Terminated NCT02373787 - A 5 Year Clinical Investigation on Creos Xenoprotect N/A
Completed NCT05869292 - Immediate Vs. Early Loading of Immediately Placed Implants N/A
Active, not recruiting NCT04027660 - Outcome of Immediate Zirconia Implants
Completed NCT02861313 - Oral Health Related Quality of Life and Peri-implant Condition in Single Implant Overdenture N/A
Not yet recruiting NCT05723926 - Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation N/A
Terminated NCT01279187 - The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone Phase 2
Completed NCT02362854 - Efficacy of Diode Laser in Peri-implantitis N/A
Terminated NCT04676061 - Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™ Phase 4
Recruiting NCT04942327 - Awareness Among Hearing Enhancement Interventions and Reimbursement Criteria of Hearing Implants N/A
Recruiting NCT05768295 - Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants N/A